- UCLA study finds combination therapy suppresses pancreatic tumor growth in mice
UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling.
February 18, 2021 9:00 AMdetail
- UCLA and more than 125 organizations send letter to Biden urging priority access to the COVID-19 vaccines for cancer patients and survivors
UCLA and more than 125 organizations and cancer centers sent a letter to President Joseph R. Biden and his administration to underscore the importance of prioritizing patients with active cancer and survivors of cancer when administering the lifesaving COVID-19 vaccines.
February 17, 2021 11:00 AMdetail
- Model helps predict which patients will benefit most from PSMA PET scan
A new study led by UCLA researchers helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET.
February 16, 2021 9:00 AMdetail
- Combination therapy with radiation shows promise in treating glioblastoma
In a study of mice, researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new approach that combines an anti-psychotic drug, a statin used to lower high cholesterol levels, and radiation to improve the overall survival in mice with glioblastoma.
February 09, 2021 9:00 AMdetail
- Want to improve care for breast cancer patients? Listen to what they say on Twitter
Information shared by women with metastatic breast cancer on social media platforms like Twitter may be a timely source of data for policymakers hoping to improve care and outcomes for these patients.
February 03, 2021 8:30 AMdetail
- Advances in radiation technology help physicians deliver more precise and effective cancer treatment
A new advance in radiation-therapy equipment is giving physicians the ability to better visualize tumors and internal anatomy, allowing more accurate delivery of necessary treatments.
February 02, 2021 12:00 PMdetail
- Experts recommend people with cancer be prioritized for the COVID-19 vaccine
People receiving chemotherapy and some other cancer treatments are particularly vulnerable to developing serious illness from COVID-19, says UCLA's Dr. Antoni Ribas says.
January 26, 2021 6:00 AMdetail
- Study finds shorter radiation regimen safe, effective for men with advanced prostate cancer
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found shortening a traditional 45-day course of radiation to a five-day course delivered in larger doses is safe and as effective as conventional radiation for men with high-risk forms of prostate cancer.
January 14, 2021 8:30 AMdetail
- Cancer researchers awarded grant to study genomic alterations in prostate cancer
Three UCLA Jonsson Comprehensive Cancer Center researchers have received the 2020 Prostate Cancer Foundation Special Challenge Award.
January 14, 2021 8:00 AMdetail
- UCLA scientists develop method to more efficiently isolate and identify rare T cells
UCLA scientists have developed a technique that will enable researchers to more efficiently isolate and identify rare T cells that are capable of targeting viruses, cancer and other diseases.
January 11, 2021 12:00 PMdetail
- MRI frequently underestimates tumor size in prostate cancer
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.
January 07, 2021 9:30 AMdetail
- More women embracing ‘going flat’ after mastectomy
A growing number of women forgoing reconstruction after a mastectomy say they’re satisfied with their choice, even as some did not feel supported by their physician, according to a study led by researchers at the UCLA Jonsson Comprehensive Cancer Center.
January 04, 2021 10:30 AMdetail
- UCLA scientists develop high-throughput mitochondria transfer device
Scientists from the UCLA Jonsson Comprehensive Cancer have developed a simple, high-throughput method for transferring isolated mitochondria and their associated mitochondrial DNA into mammalian cells.
December 29, 2020 8:00 AMdetail
- Researcher receives Young Investigator Award to investigate new stromal biomarker for prostate cancer
Dr. Jeremie Calais is one of 26 researchers to be named a 2020 Young Investigator by the Prostate Cancer Foundation.
December 16, 2020 10:00 AMdetail
- New combination therapy could help fight difficult-to-treat cancers with common mutations
Scientists at the UCLA Jonsson Comprehensive Cancer Center describe a new combination therapy that suppresses the MAPK pathway by holding cancer-driving proteins in a death grip.
December 14, 2020 8:00 AMdetail
- Gene could help predict response to cervical cancer treatment
UCLA researchers have identified a potential diagnostic marker that could help predict how likely someone with cervical cancer is to respond to the standard treatment of chemotherapy and radiation.
December 11, 2020 8:00 AMdetail
- Mindfulness meditation, survivorship classes reduce symptoms of depression in younger breast cancer survivors
New UCLA-led research shows that behavioral interventions are effective in reducing depressive symptoms in younger breast cancer survivors, who often experience the highest levels of depression, stress and fatigue that can persist for as long as a decade after their diagnosis.
December 09, 2020 1:15 PMdetail
- Researchers create framework to help determine timing of cancer mutations
UCLA Jonsson Comprehensive Cancer Center researchers studying cancer evolution have created a framework to help determine which tool combinations are best for pinpointing the exact timing of DNA mutations in cancer genomes.
December 07, 2020 8:00 AMdetail
- FDA approvals put UCLA Jonsson Comprehensive Cancer Center at leading edge of game-changing treatments
In 2020, UCLA’s Cancer Center developed treatments for liver, breast, prostate and lung cancer. Learn about all of our latest pioneering discoveries in this feature story.
December 02, 2020 4:00 PMdetail
- UCLA, UCSF gain FDA approval for prostate cancer imaging technique
The University of California’s two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.
December 01, 2020 9:30 AMdetail